Sutro Biopharma Inc (STRO)

JMP Securities Reiterates Sutro Biopharma (STRO) Market Outperform Recommendation - MSN

MSN

Q2 2024 EPS Estimates for Sutro Biopharma, Inc. (NASDAQ:STRO) Lowered by HC Wainwright - MarketBeat

MarketBeat

Sutro Biopharma Inc (STRO) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

The InvestChronicle

Market Recap: Sutro Biopharma Inc (STRO)'s Negative Momentum, Closing at 3.93 – DWinneX - The Dwinnex

The Dwinnex

HC Wainwright Comments on Sutro Biopharma, Inc.'s Q2 2024 Earnings (NASDAQ:STRO) - Defense World

Defense World

Sutro Biopharma, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.09) Per Share (NASDAQ:STRO) - Defense World

Defense World

Sutro Biopharma's (STRO) Buy Rating Reiterated at HC Wainwright - Defense World

Defense World

Oppenheimer Reiterates Outperform Rating for Sutro Biopharma (NASDAQ:STRO) - MarketBeat

MarketBeat

JMP Securities Reiterates Sutro Biopharma (STRO) Market Outperform Recommendation - MSN

MSN

Does Sutro Biopharma Inc (STRO) offer a good opportunity for investors? – Sete News - SETE News

SETE News

Deutsche Bank cuts Sutro Biopharma target to $10, maintains 'buy' - Investing.com South Africa

Investing.com South Africa

How Much Upside is Left in Sutro Biopharma, Inc. (STRO)? Wall Street Analysts Think 288% - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Sutro Biopharma shares hold on luvelta prospects - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Sutro Biopharma's (STRO) Outperform Rating Reaffirmed at Wedbush - MarketBeat

MarketBeat

Investing in Sutro Biopharma Inc (STRO) might be a great opportunity, but the stock is a bit overvalued – US Post News - US Post News

US Post News

Sutro Biopharma earnings missed by $0.03, revenue topped estimates - Investing.com South Africa

Investing.com South Africa

Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones ... - wallstreet:online

wallstreet:online

Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance Australia

Yahoo Finance Australia

The past three years for Sutro Biopharma (NASDAQ:STRO) investors has not been profitable - Yahoo Finance

Yahoo Finance

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

MarketBeat

Sutro Biopharma (NASDAQ:STRO) Now Covered by Analysts at Bank of America - Defense World

Defense World

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Defense World

Sutro Biopharma (STRO) Stock Forecast and Price Target 2024 - MarketBeat

MarketBeat

Wall Street Analysts Think Sutro Biopharma, Inc. (STRO) Could Surge 295%: Read This Before Placing a Bet - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Movies UK

Yahoo Movies UK

Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research

Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

B of A Securities Initiates Coverage of Sutro Biopharma (STRO) with Buy Recommendation - MSN

MSN

BofA starts Sutro at buy, cites ovarian cancer drug candidate (NASDAQ:STRO) - Seeking Alpha

Seeking Alpha

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Singapore News

Yahoo Singapore News

Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts - Sutro Biopharma (NASDAQ:STRO) - Benzinga

Benzinga

Sutro Biopharma (NASDAQ:STRO) Earns Buy Rating from Analysts at Bank of America - MarketBeat

MarketBeat

There is no doubt that Sutro Biopharma Inc (STRO) ticks all the boxes. – Sete News - SETE News

SETE News

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Singapore News

Yahoo Singapore News

Following a 26% decline over last year, recent gains may please Sutro Biopharma, Inc. (NASDAQ:STRO) institutional owners - Simply Wall St

Simply Wall St

Following a 26% decline over last year, recent gains may please Sutro Biopharma, Inc. (NASDAQ:STRO) institutional owners - Simply Wall St

Simply Wall St

AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock? - Yahoo Finance Australia

Yahoo Finance Australia

Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Movies UK

Yahoo Movies UK

Trading Day Triumph: Sutro Biopharma Inc (STRO) Ends at 3.52, a 2.92 Surge/Plunge – DWinneX - The Dwinnex

The Dwinnex

Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for - Yahoo Movies UK

Yahoo Movies UK

Market Momentum: Sutro Biopharma Inc (STRO) Registers a -3.71 Decrease, Closing at 3.63 – DWinneX - The Dwinnex

The Dwinnex

Deals report: Merck buying Buffalo academic spinout to enhance ADCs - BioCentury

BioCentury

Genmab joins ADC arena with $1.8bn ProfoundBio acquisition - Pharmaceutical Technology

Pharmaceutical Technology

Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering

GlobeNewswire Inc.

Ipsen licenses Sutro ADC in $900m deal - pharmaphorum

pharmaphorum

Penny Stock Sutro Biopharma (NASDAQ:STRO): Intriguing Play for Biotech Investors - TipRanks.com - TipRanks

TipRanks

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday

Benzinga

The Market Doesn't Like What It Sees From Sutro Biopharma, Inc.'s (NASDAQ:STRO) Revenues Yet - Simply Wall St

Simply Wall St